Skip to main content

IDEAYA Biosciences, Inc 8-K, filed Nov 3, 2026

IDEAYA Biosciences, Inc. (IDYA)

8-K 2026-11-03 For: 2026-11-03
View Original
Added on November 03, 2026

About this 8-K

IDEAYA Biosciences, Inc filed this 8-K on November 3, 2026.

IDEAYA Biosciences completed its darovasertib NDA submission, stopped enrollment in OptimUM-010 to save $100-125 million, and reported a $125.7 million net loss with $1.15 billion in cash and marketable securities at September 30, 2026. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits